Table 1

Baseline characteristics of participants according to RHR

Q1 (n=10 349)Q2 (n=7589)Q3 (n=9086)Q4 (n=10 127)Q5 (n=9410)F / χ2P value
Age (years)55.95±11.1852.51±11.2554.29±10.9753.37±11.2753.40±11.72118.39<0.01
Sex (male, %)85.5886.6684.1887.1486.4839.86<0.01
RHR (beats per minute)63.23±4.3670.07±0.4173.14±1.3578.66±1.6690.73±8.0053 523.5<0.01
SBP (mm Hg)145.69±16.86145.88±16.90147.09±17.57148.12±17.58150.47±18.91109.05<0.01
DBP (mm Hg)90.70±9.5392.44±9.4992.91±9.9093.89±10.5494.75±11.17214.30<0.01
BMI (kg/m2)25.88±3.3126.09±3.3726.06±3.4626.07±3.4725.79±3.6212.86<0.01
TG (mmol/L)1.74±1.341.93±1.531.84±1.451.90±1.512.04±1.6949.19<0.01
LDL-C (mmol/L)2.38±1.002.51±0.942.51±0.992.58±0.992.48±0.9253.45<0.01
HDL-C (mmol/L)1.56±0.441.58±0.411.54±0.431.53±0.401.58±0.4420.69<0.01
FBG (mmol/L)5.43±1.475.55±1.615.67±1.745.80±1.866.15±2.32207.52<0.01
Diabetes (%)8.679.5310.3212.6316.25316.85<0.01
Physical exercise (%)18.5716.3721.5617.8714.09177.32<0.01
Smoking (%)39.7239.0542.2343.6640.8549.70<0.01
Drinking (%)42.0639.8642.4943.7940.8531.08<0.01
Antihypertensive medication (%)24.6018.0522.2321.7721.3998.01<0.01
History of myocardial infarction1.911.541.681.671.515.770.217
History of stroke4.102.953.213.233.0025.55<0.001
  • Q1: RHR ≤68 bpm; Q2: RHR >68 and ≤72 bpm; Q3: RHR >72 and ≤76 bpm; Q4: RHR >76 and ≤82 bpm; Q5: RHR >82 bpm.

  • BMI, body mass index; bpm, beats per minute; DBP, diastolic blood pressure; FBG, fasting blood glucose; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; RHR, resting heart rate; SBP, systolic blood pressure; TG, triglycerides.